Global Oligonucleotide Synthesis Market to 2025 - Continuous Rise in Usage of Oligonucleotide Synthesis Across Various Aspects of Human Health Management, from Molecular Diagnostics to Therapeutics

DUBLIN, Nov. 19, 2018 /PRNewswire/ --

The "Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By End Use, By Product (Column-based, Array-based, Services), By Application (PCR Primer, FISH), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global oligonucleotide synthesis market size is expected to reach USD 3.9 billion by 2025 at a 12.4% CAGR during the forecast period.

Continuous rise in usage of oligonucleotide synthesis across various aspects of human health management, from molecular diagnostics to therapeutics, is spurring revenue growth.

The recent success of oligonucleotide-based drugs in medicine due to increase in number of FDA-approved products is anticipated to boost revenue generation in this market. As of September 2017, there are six approved oligonucleotide therapeutic products.

A substantial number of oligos are being investigated for their usage in targeting various infectious diseases. For instance, dsDNA thioaptamers are reported to target the ribonuclease H (RNase H) domain of HIV-RT and are demonstrated to inhibit HIV-RT when used in vitro.

In addition, demand for cancer-related thioapatmers that can detect presence as well as target tumor growth factors, such as TGF-, is on a continuous rise. This, in turn, has led to increase in investments for exploring the significance of custom oligonucleotide synthesis in cancer research.

Key Topics Covered:

Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Research Methodology
2.1 Information procurement
2.2 Information or Data Analysis
2.3 Market Formulation - Validation
2.4 Approaches for Market Estimation

Chapter 3 Oligonucleotide Synthesis Market Variables, Trends - Scope
3.1 Market Segmentation - Scope
3.1.1 Market driver analysis
3.1.1.1 Strong pipeline of oligonucleotide therapeutics in clinical trials
3.1.1.2 Changing regulatory environments for genetic research and its applications in healthcare
3.1.1.3 High R - D spending of pharmaceutical - biotechnology companies
3.1.1.4 Increased public - private spending on genomics
3.1.1.5 Technological advancements in gene editing technologies
3.1.1.6 Exponentially declining cost of sequencing
3.1.1.7 Rising demand for synthetic genes
3.1.2 Market restraint analysis
3.1.2.1 Need for advanced oligo synthesis solutions
3.1.2.2 High cost associated with genomics research
3.1.2.3 Increasing wages of skilled employees in life science sector
3.1.2.4 Lack of skilled professionals and research support in undeveloped countries
3.2 Penetration - Growth Prospect Mapping for Application, 2017
3.3 Oligonucleotide Synthesis -SWOT Analysis, By Factor (Political - Legal, Economic And Technological)
3.4 Industry Analysis - Porter's

Chapter 4 Oligonucleotide Synthesis Market Categorization: Product Estimates - Trend Analysis
4.1 Global Oligonucleotide Synthesis Market: Product Movement Analysis, 2017 - 2025
4.2 Oligonucleotides
4.2.1 Global oligonucleotides market, 2014 - 2025 (USD Million)
4.2.2 Oligonucleotides, by product type
4.2.2.1 Column-based oligos
4.2.2.2 Array-based oligos
4.2.3 Oligonucleotides, by nucleic acid type
4.2.3.1 DNA oligos
4.2.3.2 RNA oligos
4.3 Equipment/ Synthesizers
4.4 Reagents
4.5 Services
4.5.1 Global oligonucleotide services market, 2014 - 2025 (USD Million)
4.5.2 Oligo synthesis
4.5.2.2 25 nmol
4.5.2.3 50 nmol
4.5.2.4 200 nmol
4.5.2.5 1,000 nmol
4.5.2.6 10,000 nmol
4.5.3 Purification
4.5.4 Modification

Chapter 5 Oligonucleotide Synthesis Market Categorization: Application Estimates - Trend Analysis
5.1 Global Oligonucleotide Synthesis Market: Application Movement Analysis, 2017 - 2025
5.2 PCR primers
5.3 PCR Assays - Panels
5.4 Sequencing
5.5 DNA Microarrays
5.6 Fluorescence In Situ Hybridization (FISH)
5.7 Antisense Oligonucleotides
5.8 Other Applications

Chapter 6 Oligonucleotide Synthesis Market Categorization: End Use Estimates - Trend Analysis
6.1 Global Oligonucleotide Synthesis Market: End Use Movement Analysis, 2017 - 2025
6.2 Pharmaceutical - Biotechnology Companies
6.3 Diagnostic Laboratories
6.4 Academic Research Institutes

Chapter 7 Oligonucleotide Synthesis Market Categorization: Regional Estimates - Trend Analysis, by Product, Applications, - End Use
7.1 Oligonucleotide Synthesis Market Share By Region, 2017 - 2025

Chapter 8 Competitive Landscape

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• GE Healthcare Dharmacon Inc.
• Agilent Technologies
• Bio-synthesis
• Kaneka Eurogentec S.A.
• Integrated DNA Technologies, Inc.
• BioAutomation
• LGC Biosearch Technologies
• Biolegio B.V.

For more information about this report visit https://www.researchandmarkets.com/research/z5dk9t/global?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets